4//SEC Filing
INTERCEPT PHARMACEUTICALS INC 4
Accession 0001144204-15-051625
CIK 0001270073operating
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 9:00 PM ET
Size
12.1 KB
Accession
0001144204-15-051625
Insider Transaction Report
Form 4
WILLIAMS NICOLE
Director
Transactions
- Exercise/Conversion
Common Stock
2015-08-20$9.82/sh+865$8,496→ 1,936 total - Sale
Common Stock
2015-08-20$206.85/sh−974$201,472→ 962 total - Exercise/Conversion
Options to Purchase Common Stock
2015-08-20−109→ 0 totalExercise: $9.82Exp: 2018-09-18→ Common Stock (109 underlying) - Exercise/Conversion
Options to Purchase Common Stock
2015-08-20−865→ 3,894 totalExercise: $9.82Exp: 2019-09-16→ Common Stock (865 underlying) - Exercise/Conversion
Common Stock
2015-08-20$9.82/sh+109$1,071→ 1,071 total
Footnotes (2)
- [F1]The reported transaction was made pursuant to a 10(b)5-1 plan adopted by the reporting person on November 21, 2014.
- [F2]All shares underlying this option have vested.
Documents
Issuer
INTERCEPT PHARMACEUTICALS INC
CIK 0001270073
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001270073
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 9:00 PM ET
- Size
- 12.1 KB